Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Overweight Trial in United States (LY3305677, Placebo)

Not yet recruiting
  • Obesity
  • Overweight
  • Mesa, Arizona
  • +27 more
Nov 21, 2023

Type 1 Diabetes, Obesity Trial in Chicago (Time restricted eating, Daily calorie restriction)

Recruiting
  • Type 1 Diabetes
  • Obesity
  • Time restricted eating
  • Daily calorie restriction
  • Chicago, Illinois
    University of Illinois Chicago
Nov 11, 2023

Obesity Trial in United States (Cagrilintide, Semaglutide, Tirzepatide)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +44 more
Nov 9, 2023

Obesity, Overweight and Obesity Trial in United States (LY3305677, Placebo)

Not yet recruiting
  • Obesity
  • Overweight and Obesity
  • Mesa, Arizona
  • +23 more
Nov 6, 2023

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity, Overweight, Osteo Arthritis Knee Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Phoenix, Arizona
  • +67 more
Jul 10, 2023

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Obesity Trial in Chicago (Adaptive SMARTer intervention (SMARTer), Diabetes Prevention Program Participants (DPP))

Not yet recruiting
  • Obesity
  • Adaptive SMARTer intervention (SMARTer)
  • Diabetes Prevention Program Participants (DPP)
  • Chicago, Illinois
    Northwestern University
May 8, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Concord, California
  • +147 more
Jan 24, 2023

Obesity Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +225 more
Jan 24, 2023

Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)

Recruiting
  • Diabetes Mellitus
  • Obesity
  • Centreville, Alabama
  • +55 more
Jan 18, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Obesity, Smoking Cessation, Physical Inactivity Trial in Chicago (multiple behavior change therapy)

Not yet recruiting
  • Obesity
  • +2 more
  • multiple behavior change therapy
  • Chicago, Illinois
    Northwestern University-Feinberg School of Medicine
Jan 6, 2023

Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

Completed
  • Genetic Obesity
  • +2 more
  • Birmingham, Alabama
  • +57 more
Dec 22, 2022

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

CARDIOMETABOLIC CONDITIONS, Obesity, Pre-diabetes Trial in Chicago, Saint Louis, Pittsburgh (Base intervention, Augmented

Not yet recruiting
  • CARDIOMETABOLIC CONDITIONS
  • +6 more
  • Base intervention
  • Augmented Intervention
  • Chicago, Illinois
  • +2 more
Dec 8, 2022

Polycystic Ovary Syndrome, Obesity Trial in Chicago (6-h Time restricted eating (TRE), Calorie restriction (CR), Control)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • Obesity
  • 6-h Time restricted eating (TRE)
  • +2 more
  • Chicago, Illinois
    University of Illinois Chicago
Nov 17, 2022

Surgical Site Infection, Obesity, Diabetes Trial in United States (Negative Pressure Wound Therapy)

Completed
  • Surgical Site Infection
  • +3 more
  • Negative Pressure Wound Therapy
  • Atlanta, Georgia
  • +4 more
Nov 17, 2022

Asthma, Obesity Trial in United States (Roflumilast 500 Mcg Oral Tablet, Placebo oral capsule)

Completed
Has Results
  • Asthma
  • Obesity
  • Roflumilast 500 Mcg Oral Tablet
  • Placebo oral capsule
  • Birmingham, Alabama
  • +6 more
Sep 9, 2022

Obesity Trial (Standard behavioral weight loss program, Tailored behavioral weight loss program)

Recruiting
  • Obesity
  • Standard behavioral weight loss program
  • Tailored behavioral weight loss program
  • Chicago, Illinois
    Rush University Medical Center
Sep 1, 2022

Overweight, Obesity Trial in Worldwide (Gelesis100, )

Completed
Has Results
  • Overweight
  • Obesity
  • Gelesis100
  • placebo
  • Anaheim, California
  • +35 more
Aug 8, 2022

Time Restricted Eating, Obesity, Weight Loss Trial in Chicago (Time restricted eating, Calorie Restriction)

Recruiting
  • Time Restricted Eating
  • +3 more
  • Time restricted eating
  • Calorie Restriction
  • Chicago, Illinois
    University of Illinois at Chicago
Aug 22, 2022

Iron-deficiency, Pregnancy Anemia, Obesity Trial in Chicago (Jarrow Formulas Oral Bovine Lactoferrin Supplement)

Enrolling by invitation
  • Iron-deficiency
  • +2 more
  • Jarrow Formulas Oral Bovine Lactoferrin Supplement
  • Chicago, Illinois
    University of Illinois at Chicago
Aug 15, 2022

B-cell Acute Lymphoblastic Leukemia, Obesity Trial in United States (IDEAL2 Intervention)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Obesity
  • IDEAL2 Intervention
  • Los Angeles, California
  • +15 more
Jun 23, 2022